[HTML][HTML] The Potential Risk of Reduced Serum Cholinesterase Activity in COVID-19 Patients Suffering From Cytokine Storm
Methods We determined the serum ChE activity, electrometrically, among hospitalized
COVID-19-cytokine storm patients and their non-cytokine storm counterparts. Aliquots of …
COVID-19-cytokine storm patients and their non-cytokine storm counterparts. Aliquots of …
[HTML][HTML] Evaluation of Olfactory Dysfunction Among COVID-19 Patients in Baghdad, Iraq
MF Kasim, AM Abbas - Cureus, 2024 - ncbi.nlm.nih.gov
Background SARS‑CoV‑2 (COVID-19) causes olfactory dysfunction which is characterized
by anosmia or hyposmia. Characterization of olfactory dysfunction has added value to the …
by anosmia or hyposmia. Characterization of olfactory dysfunction has added value to the …
Evaluation of first hospital entry and hospitalization related prescription polypharmacy targeting patients of fifty years old and more at a general hospital, Duhok, Iraq …
KN Mijk, KH Alyas, MH Haji, WK Ali… - Journal of Ideas in …, 2024 - jidhealth.com
Background: Polypharmacy is the intake of≥ 5 medications. This study evaluates the
prevalence of polypharmacy among elderly patients hospitalized during October 2023 at …
prevalence of polypharmacy among elderly patients hospitalized during October 2023 at …
Mini meta-analysis of anticholinesterase actions of atorvastatin, simvastatin and rosuvastatin and in silico identification of their protein targets in Mus musculus
FK Mohammad, RF Al-Shalchi - 2024 - osf.io
OSF Registries | Mini meta-analysis of anticholinesterase actions of atorvastatin, simvastatin and
rosuvastatin and in silico identification of their protein targets in Mus musculus OSF Registries …
rosuvastatin and in silico identification of their protein targets in Mus musculus OSF Registries …